Ireland
--:--IST
Latest
Clinical Trials in France / NCT06332521
Recruiting Observational

Infant Crying, a Bioacoustic Prognostic Signal for Neurodevelopment

NCT06332521 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2024-03-20
Last updated
2025-05-28

Condition(s) studied

Newborn; VitalityPremature InfantsInfant Development

Investigational drug(s) / intervention(s)

Acoustic signal analysis method

Acoustic signal analysis method: Evaluate at birth in 2 characterized populations of babies born at term or prematurely, the correlation between bioacoustic characteristic of a cry specific to each baby, with the neurodevelopmental data at 2 years.

Study summary

Crying is a vital communication signal for the baby. Product of a complex physiological process, it reflects not only the organization and functioning of the cortical central nervous system and the function of sympathetic and parasympathetic autonomic regulation but also the integrity of three entities: the lungs responsible for ventilatory mechanics and respiratory rhythm, the larynx and its vocal cords as a phonatory organ, and the oropharyngeal tract guaranteeing the resonance of the sound emitted by the vocal cords.

Crying is usually caused by pain, discomfort, hunger, or separation from parents or other caregivers. Crying carries essential information from birth, the expression of which depends closely on the neuroanatomical and functional brain integrity of the child. On a bioacoustic level, crying consists of sequences of complex acoustic signals produced by the vocal folds and filtered by the vocal tract. The vibration frequency of the vocal cords determines the cry's fundamental frequency f0 (and the harmonic frequencies), which is responsible for its more or less low or high pitch. Other acoustic cues also characterize each baby's cry.

Eligibility

Sex
ALL
Min age
—
Max age
4 Days
Healthy volunteers
Accepted
Inclusion Criteria: * For a full-term baby \> 37 weeks * For a premature baby \< 37 weeks * Born in the maternity ward of the Saint-Etienne University Hospital * Holder of parental authority having received informed information about the study and their right to object * Holder of parental authority affiliated to or beneficiary of a social security system * Eutrophic between the 10th and 90th percentile on the neonatal curves) Exclusion Criteria: * Refusal of participation by the holder of parental authority * Antenatal pathology, nor perinatal asphyxia * Holder of minor parental authority * Holder of parental authority under curatorship or guardianship * Abnormal T1 audiological screening test.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Chu de Saint-Etienne Saint-Etienne France Recruiting

More Centre Hospitalier Universitaire de Saint Etienne trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06332521 on ClinicalTrials.gov ↗ ← All trials in France